Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein.
Journal: Journal of chemical information and modeling
Published: November 05, 2024
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind Study.
Journal: Critical care explorations
Published: March 21, 2024
Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease.
Journal: Current Alzheimer research
Published: September 20, 2023
Computer-aided drug design to generate a unique antibiotic family.
Journal: Nature communications
Published: July 13, 2022
Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 08, 2021
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: March 15, 2021
Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
Journal: The American journal of the medical sciences
Published: May 11, 2020
Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide.
Journal: PeerJ
Published: April 13, 2020
The Brain Exposure Efficiency (BEE) Score.
Journal: ACS chemical neuroscience
Published: December 10, 2019
The Blood-Brain Barrier (BBB) Score.
Journal: Journal of medicinal chemistry
Published: October 12, 2019
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: July 26, 2019
Last Updated: 09/26/2026